Head

Based on a 365-page review published by FDA last month, safety experts recommended the ban of decongestant for use in children under 2 years old and antihistamines in children younger than 6. The recommendation suggested that these formulations be taken out of the market. It also proposed the standardization of products for infants like syringes, droppers and cups to reduce confusion and overdose. The proposed warning included approximately 800 popular medicines sold in the United States. [Read more]